Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

The Impact of Wellness Programs on Worker’s Compensation Claims

31/08/2022The Impact of Wellness Programs on Worker’s Compensation Claims

Employee wellness is becoming an increasing point of emphasis in recent years. Worker burnout is one of the leading causes of individuals choosing to leave their jobs, along with poor work/life balance and not feeling valued. When employees do not feel that th

One Wrong Click Could Expose Firms That Only Think They Are Cyber Secure, Expert Warns

19/05/2026One Wrong Click Could Expose Firms That Only Think They Are Cyber Secure, Expert Warns

In this exclusive interview with the Cyber Security Speakers Agency, Phillip Wylie explains where businesses are giving themselves false confidence, how hackers are changing tactics as defences improve, and why security teams need to keep learning before crimi

Artificial Intelligence Causes New Challenges For Research Ethics At Universities

11/01/2018Artificial Intelligence Causes New Challenges For Research Ethics At Universities

The acceleration of knowledge and the emergence of new technologies, such as artificial intelligence (AI), has provoked new ethical questions and requires universities to approach research ethics differently, says Professor Sylvie Pommier, Director of Doctoral

Key Legal Considerations When Drafting a Business Contract

01/05/2024Key Legal Considerations When Drafting a Business Contract

A well-written business contract is like an insurance policy, protecting you and your business in the event of something going wrong, and failing to have a written contract in place can be a costly mistake in the event of a contractual breach or a dispute.

5 ways that SMEs can overcome cash flow challenges in uncertain markets

01/11/20245 ways that SMEs can overcome cash flow challenges in uncertain markets

Across the UK, many small and medium-sized enterprises (SMEs) face financial pressures due to a variety of factors, including fluctuating economic conditions and rising operational costs. These challenges often leave business owners searching for reliable stra

Investment Management of the Future

20/06/2023Investment Management of the Future

EXtrance is revolutionising the real estate fund sector with state-of-the-art technology. The company was founded in 2020 by real estate investment expert, William Lively.

06/01/2022Turning a Struggling Brand into a Triumph: the ABC to Success

Instability throughout the retail sector came to the fore during the pandemic as established brands struggled to overcome their outdated business models. However, the challenges faced by these brands began the well before the pandemic as market fluctuations ca

Altor & Goldman Sachs Merchant Banking Division Acquires Majority stake in Hamlet Protein.

22/07/2015Altor & Goldman Sachs Merchant Banking Division Acquires Majority stake in Hamlet Protein.

Altor & Goldman Sachs Merchant Banking Division Acquires Majority stake in Hamlet Protein.

Low Transmission Fluid Pressure: A Hidden Post-Collision Risk for Businesses

27/01/2026Low Transmission Fluid Pressure: A Hidden Post-Collision Risk for Businesses

For many businesses, vehicle reliability is directly tied to operational continuity, cost control, and risk exposure. Transmission failures are often categorised as routine mechanical wear, particularly when they occur sometime after a collision. However, many

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS